BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 27760547)

  • 1. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
    Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
    BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R; Afonso S; Peces C; Nevado J; Selgas R
    BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
    Abedi AS; Nakhjavani JM; Etemadi J
    Transplant Proc; 2013; 45(10):3502-4. PubMed ID: 24314942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Mediterranean fever-associated renal amyloidosis: case report and review of the literature.
    Andronesi AG; Ismail G; Gherghiceanu M; Mitroi G; Hârza MC
    Rom J Morphol Embryol; 2019; 60(4):1299-1303. PubMed ID: 32239108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever.
    Altindal M; Turkmen E; Yildirim T; Yilmaz R; Aki FT; Arici M; Altun B; Erdem Y
    Clin Transplant; 2016 Jul; 30(7):787-90. PubMed ID: 27101228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever.
    Yildiz A; Akkaya V; Kiliçaslan I; Türkmen A; Görçin B; Atilgan D; Sever MS
    J Nephrol; 2001; 14(2):125-7. PubMed ID: 11411014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
    Keven K; Sengul S; Kutlay S; Ekmekci Y; Anadol E; Nergizoglu G; Ates K; Erturk S; Erbay B
    Transplant Proc; 2004 Nov; 36(9):2632-4. PubMed ID: 15621109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
    Hamanoue S; Suwabe T; Hoshino J; Sumida K; Mise K; Hayami N; Sawa N; Takaichi K; Fujii T; Ohashi K; Yazaki M; Ikeda S; Ubara Y
    Mod Rheumatol; 2016 Jul; 26(4):610-3. PubMed ID: 25619282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever.
    Abdel Halim MM; Al-Otaibi T; Donia F; Gheith O; Asif P; Nawas M; Rashad RH; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2015 Apr; 13(2):188-92. PubMed ID: 24650330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of familial Mediterranean fever-associated systemic amyloidosis.
    Nakamura N; Fujita T; Murakami R; Kumasaka R; Shimada M; Shimaya Y; Osawa H; Yamabe H; Okumura K; Yachie A
    CEN Case Rep; 2012 May; 1(1):4-6. PubMed ID: 28509144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
    Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
    J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal involvement, presence of amyloidosis, and genotype-phenotype relationship in pediatric patients with Familial Mediterranean fever: a single center study.
    Bekis Bozkurt H; Yıldırım S; Ergüven M
    Eur J Pediatr; 2023 Apr; 182(4):1911-1919. PubMed ID: 36807513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid goiter as the initial manifestation of systemic amyloidosis due to familial mediterranean fever with homozygous MEFV mutation.
    Sbai A; Wechsler B; Leenhardt L; Beaufils H; Hoang C; Ménégaux F; Piette JC
    Thyroid; 2001 Apr; 11(4):397-400. PubMed ID: 11349841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.
    Ben-Zvi I; Danilesko I; Yahalom G; Kukuy O; Rahamimov R; Livneh A; Kivity S
    Isr Med Assoc J; 2012 Apr; 14(4):221-4. PubMed ID: 22675837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Diagnosis of E148Q Mutation-Positive Familial Mediterranean Fever in a Kidney Transplant Patient With Fever of Unknown Origin: A Case Report.
    Tatar E; Uslu A; Simsek C; Aykas A; Bozkaya G; Imamoglu C
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):261-264. PubMed ID: 28260482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.
    Trabulus S; Korkmaz M; Kaya E; Seyahi N
    Clin Transplant; 2018 Aug; 32(8):e13345. PubMed ID: 29981275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
    Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
    Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome.
    Cakar N; Yalçinkaya F; Ozkaya N; Tekin M; Akar N; Koçak H; Misirlioğlu M; Akar E; Tümer N
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S63-7. PubMed ID: 11760404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.